TruSculpt iD & Hormonal Fat Loss
At Glow by Elena Reitman MD in Cresskill, NJ, we recognize that effective body contouring involves more than just external devices—it requires a deep understanding of your internal biology. A sophisticated question we often address is whether significant hormonal shifts, such as those experienced during perimenopause or while undergoing testosterone therapy, will alter the success rate of fat cell elimination following a TruSculpt iD session.
It is critical to distinguish between the destruction of fat and the removal of fat. The destructive phase of TruSculpt iD is driven strictly by physics. The device utilizes clinical-grade Monopolar Radiofrequency to heat subcutaneous adipose tissue to a precise therapeutic temperature. This triggers apoptosis (cell death) in roughly 24% of the fat cells in the treatment zone.
Patients navigating perimenopause may have a slightly more sluggish lymphatic response, meaning the body requires more time to filter out the destroyed fat cells. Similarly, testosterone therapy can sometimes increase water retention, which might temporarily mask the slimming effect. Dr. Elena Reitman applies her medical expertise to navigate these nuances. By reviewing your hormonal health, she can adjust expectations and recommend specific lymphatic support protocols. This ensures that even with a shifting endocrine system, your body efficiently processes the treatment for permanent, visible sculpting.
from GMB Posts For Location "Glow by Elena Reitman MD" https://ift.tt/ZofYMpC
No comments:
Post a Comment